Introduction {#s1}
============

The inner ear is derived from a simple patch of otic placode adjacent to the hind brain. After formation of the otic cup and vesicle, otic neuroblasts delaminate from the otic epithelium around E9.0 by initiating neurogenic gene-mediated programs, such as neurogenin1. These neural precursors generate otic neurons, which are also known as cochleovestibular ganglion (CVG) cells [@pone.0097544-Coate1]. After CVG complexes are separated into the spiral and vestibular ganglion, developing spiral ganglion neurons (SGNs) promote neuronal outgrowth between E12.5 and E15.5, and regulate peripheral axon guidance to synapse with their target hair cells [@pone.0097544-Bell1], [@pone.0097544-Appler1]. This process of auditory neurogenesis depends on well-organized complex signaling networks comprised of trophic factors such as phosphatidylinositol 3 kinase (PI3K)/Akt and insulin-like growth factor I (IGF-I), as well as morphogens, including the Wnt family, cell adhesion molecules and transcriptional regulators [@pone.0097544-SanchezCalderon1]--[@pone.0097544-Salinas1]. Several studies of knockout mice and *in vitro* cultures have provided evidence of their important roles in neural survival, neurite outgrowth and nerve innervations to target hair cells of the inner ear [@pone.0097544-Camarero1], [@pone.0097544-Yang1], [@pone.0097544-Appler2]. However, spatiotemporal gene expression and the complex molecular networks in neuronal development in the inner ear are not yet fully understood.

Phosphatase and tensin homologue (PTEN), a lipid phosphatase, is negatively regulated by PI3K signaling and contributes to cellular processes including proliferation, differentiation and migration [@pone.0097544-Myers1]--[@pone.0097544-Li1]. Many studies have investigated the function of *Pten* loss in mice, which causes profound alterations in the regulation of cellular maintenance in a cell-type specific manner in various organs [@pone.0097544-Kim1]--[@pone.0097544-Marino1]. Recently, we characterized the phenotype of inner-ear-specific *Pten* conditional knockout (cKO) mice, which demonstrated abnormal phenotypes (e.g., ectopic hair cells in the cochlear sensory epithelium and neuronal defects) [@pone.0097544-Kim1]. In particular, mouse inner ear lacking *Pten* had neuronal deficits such as disorganized nerve fibers with apoptosis of spiral ganglion. Thus, *Pten* is believed to be one of the functional regulators that maintain differentiation of SGNs during inner ear development.

Understanding of the signaling networks during inner ear development may provide molecular information regarding the pathways underlying the maintenance of sensory cells and neurons to prevent hearing impairment. Microarray analysis may provide information that allows prediction of novel signaling networks by analyzing the spatiotemporal pattern of gene expression during inner ear neurogenesis [@pone.0097544-Lu1]--[@pone.0097544-Milo1]. Thus, analysis of changes in gene expression profiles and signaling networks obtained from *Pten* mutants may identify potential novel targets and regulatory mechanisms associated with neuronal maintenance during inner ear development. In this study, we explored otic neuron-specific targets of *Pten* signaling to further understand its function in the development of SGNs and the causes of aberrant neural differentiation associated with the *Pten*-deficient inner ear. Our results suggest that secreted phosphoprotein 1 (*Spp1*) and G-protein signaling 4 (*Rgs4*)-mediated networks maintain the neuronal differentiation underlying spiral ganglion development in *Pten*-deficient mice.

Materials and Methods {#s2}
=====================

Ethics statement {#s2a}
----------------

All mouse procedures were performed according to the guidelines for the use of laboratory animals and were approved by the Institutional Animal Care and Use Committee at Korea Centers for Disease Control and Prevention (KCDC-018-12-1A).

Tissue dissection and RNA extraction {#s2b}
------------------------------------

The generation and characterization of inner ear-specific *Pten* cKO (*Pax2^Cre/+^*; *Pten^loxP/loxP^*) and wild-type (*Pten^loxP/+^* or *Pten^loxP/loxP^*) mice was described previously [@pone.0097544-Kim1]. *Pten* cKO and littermate wild-type mice were used on E14.5 (60 embryos from each group). The entire inner ear tissues including the cochlea and vestibule, as well as the surrounding otic capsule, were micro-dissected in sterile, chilled phosphate-buffered saline (PBS) under a stereomicroscope (Olympus SZ61, Olympus Corporation, Tokyo, Japan). Three independent pools of inner ear tissues from each group were homogenized with a tissue grinder (Kimble Chase, Vineland, NJ, USA). Total RNA from three independent pools of inner ears was extracted with TRIzol following the manufacturer\'s instructions (Invitrogen, Carlsbad, CA, USA). To eliminate DNA contamination, total RNA was treated with DNase I (Roche Applied Science, Mannheim, Germany) before use in the microarray analysis or real-time polymerase chain reaction (RT-PCR). The concentration and purity of extracted total RNA were measured using both the spectrophotometric method at 260 and 280 nm, and RNA electrophoresis.

Microarray data analysis {#s2c}
------------------------

Gene expression profiles were generated using the Illumina MouseRef-8 version 2.0 Expression BeadChip (Illumina, Inc., San Diego, CA, USA). Three biological replicates (three chips for wild-type samples and three chips for *Pten* cKO samples) were performed for microarray hybridization experiments. Biotinylated cRNA was prepared from 550 ng total RNA using the Illumina TotalPrep RNA Amplification kit (Ambion, Austin, TX, USA). Following fragmentation, 750 ng of cRNA was hybridized to the Illumina MouseRef-8 version 2.0 Expression Beadchip according to the manufacturer\'s instructions. Array chips were scanned using the Illumina Bead Array Reader Confocal scanner. Microarray data were analyzed using Illumina GenomeStudio Gene expression Module (version 1.5.4) and deposited in NCBI Gene Expression Omnibus Database (GEO, <http://www.ncbi.nlm.nih.gov/geo/>) (\#GSE49562) in agreement with the MIAME requirements. The significance analysis microarrays (SAM) software was used with the false-discovery rate (FDR) set at 0 or 0.05. SAM (FDR = 0) allowed the identification of genes whose expression varied significantly between the wild-type and *Pten* cKO groups [@pone.0097544-Tusher1]. Hierarchical clustering was carried out using the R software [@pone.0097544-Dudoit1]. Ingenuity Pathway Analysis (IPA; Ingenuity Systems, <http://www.ingenuity.com>) tools were used to analyze possible functional relationships between selected differentially expressed genes (DEGs).

Quantitative reverse-transcription PCR {#s2d}
--------------------------------------

Quantitative real-time PCR (qRT-PCR) was performed to validate the microarray data. Each pooled RNA sample was converted to cDNA using random hexanucleotide primers with a High Capacity cDNA Reverse Transcription kit according to the manufacturer\'s instructions (Applied Biosystems, Carlsbad, CA, USA). The list of PCR primer sequences for selected genes is provided in [Table S1](#pone.0097544.s002){ref-type="supplementary-material"}. 18S rRNA was used as an endogenous control for normalization. The PCR reaction was performed in quadruplicate using SYBR Green PCR Master Mix and an ABI 7500 machine with the version 2.0.6 software under the following conditions (Applied Biosystems): denaturation at 95°C for 10 min followed by 40 cycles of amplification (95°C for 15 sec, 60°C for 1 min). The relative expression level of each target gene in an experimental sample compared with the wild-type sample was analyzed using SDS Relative Quantification (RQ) Manager software as described by the manufacturer (Applied Biosystems). RQ levels were calculated using the comparative C~T~ (2^−ΔΔCT^) method [@pone.0097544-Livak1]. Relationships between the microarray data and qRT-PCR were analyzed using Pearson\'s correlation coefficient (*r*) from GraphPad Prism (GraphPad Software, <http://www.graphpad.com>).

*In Situ* hybridization {#s2e}
-----------------------

For E14.5 embryos, pregnant mice were sacrificed by decapitation and fixed in 4% paraformaldehyde in PBS overnight at 4°C, dehydrated in 30% sucrose in PBS overnight at 4°C, placed in embedding medium (Tissue Tek OCT compound; Torrance, CA, USA), and stored at −80°C until use. Tissues were sectioned at 10-µm thickness for *in situ* hybridization, which was performed as described previously, with minor modifications [@pone.0097544-Morsli1]. At least three embryos were tested for each selected gene at E14.5. Sense RNA probes were also included as controls, which showed no signal in the inner ear. All primers for RNA probes for otoancorin (*Otoa*), β-tectorin (*Tectb*), parvalbumin (*Pvalb*), *Spp1*, and *Rgs4* are listed in [Table S1](#pone.0097544.s002){ref-type="supplementary-material"}.

Results and Discussion {#s3}
======================

Identification of genes differentially expressed between wild-type and *Pten* cKO mice at E14.5 {#s3a}
-----------------------------------------------------------------------------------------------

Recently, we reported that *Pten* cKO mice showed severe abnormalities in neuronal maintenance with increased production of hair cells during inner ear development [@pone.0097544-Kim1]. To identify the changes caused by *Pten* deficiency-induced regulation of genes in the developing inner ear, we analyzed DEGs within inner ears at E14.5. Using SAM analysis, we identified a total of 46 transcripts with an FDR = 0 that significantly distinguished the wild-type and *Pten* cKO groups. Among the transcripts, 45 genes were upregulated and one was downregulated in *Pten* cKO mice, and are listed in [Table 1](#pone-0097544-t001){ref-type="table"}. While the patterns of gene expression between *Pten* cKO and wild-type samples were highly similar according to pair-wise comparisons with correlation coefficients (data not shown), 46 DEGs were significantly selected, and their segregation was clearly shown by clustering analysis of a heat map ([Fig. 1](#pone-0097544-g001){ref-type="fig"}).

![Microarray analysis identifies novel *Pten* targets.\
Heat maps for relative gene expression of interest (FDR = 0) obtained from three microarrays comparing *Pten* cKO to wild-type embryos. Green and red indicate decreased and increased expression, respectively, in *Pten* cKO mice.](pone.0097544.g001){#pone-0097544-g001}

10.1371/journal.pone.0097544.t001

###### Differentially expressed genes in wild-type and *Pten* cKO mice at E14.5.

![](pone.0097544.t001){#pone-0097544-t001-1}

  Target ID        Gene symbol                                   Definition                                  Fold change
  -------------- --------------- -------------------------------------------------------------------------- -------------
  ILMN_2443330         Ttr                                     transthyretin                                    3.94
  ILMN_2754364         Ltf                                    lactotransferrin                                  2.28
  ILMN_2710905       S100a8                   S100 calcium binding protein A8 (calgranulin A)                   2.00
  ILMN_1260585        Stfa2                                      stefin A2                                      1.89
  ILMN_1259546         Pyy                                       peptide YY                                     1.87
  ILMN_2803674       S100a9                   S100 calcium binding protein A9 (calgranulin B)                   1.85
  ILMN_2690603        Spp1                               secreted phosphoprotein 1                              1.83
  ILMN_2634484        Tectb                                    tectorin beta                                    1.71
  ILMN_2988931        Stfa1                                      stefin A1                                      1.70
  ILMN_2735754        Otoa                                       otoancorin                                     1.67
  ILMN_2596522         Mt1                                   metallothionein 1                                  1.67
  ILMN_2712075        Lcn2                                      lipocalin 2                                     1.65
  ILMN_2805372        Itgb6                                   integrin beta 6                                   1.64
  ILMN_2648669        Gpnmb                           glycoprotein (transmembrane) nmb                          1.64
  ILMN_1251894         Dct                                 dopachrome tautomerase                               1.57
  ILMN_1244081        Rgs4                           regulator of G-protein signaling 4                         1.56
  ILMN_1228497        Esrrb                           estrogen related receptor, beta                           1.56
  ILMN_1244169        Sftpd                           surfactant associated protein D                           1.52
  ILMN_2933022       Plekhb1        pleckstrin homology domain containing, family B (evectins) member 1         1.52
  ILMN_1226157       Pik3r3        phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55)       1.52
  ILMN_1244829        Hap1                            huntingtin-associated protein 1                           1.51
  ILMN_2955694        Spag1                              sperm associated antigen 1                             1.49
  ILMN_2995688      EG433016                              predicted gene, EG433016                              1.46
  ILMN_1213954        Sgk1                        serum/glucocorticoid regulated kinase 1                       1.45
  ILMN_2769777         Msc                                        musculin                                      1.45
  ILMN_2629112       Asah3l                       N-acylsphingosine amidohydrolase 3-like                       1.44
  ILMN_1258853        Igsf1              immunoglobulin superfamily, member 1, transcript variant 4             1.42
  ILMN_2768972       Fam107a                   family with sequence similarity 107, member A                    1.41
  ILMN_2826110         Cat                                        catalase                                      1.41
  ILMN_2625893        Ces3                                   carboxylesterase 3                                 1.40
  ILMN_2766604        Camp                           cathelicidin antimicrobial peptide                         1.40
  ILMN_1229131        Wfdc3                           WAP four-disulfide core domain 3                          1.40
  ILMN_2718589        Fcna                                       ficolin A                                      1.40
  ILMN_1220193       Slc26a4                         solute carrier family 26, member 4                         1.39
  ILMN_2941888        Gm414                                    gene model 414                                   1.39
  ILMN_2684093        Rec8                                  REC8 homolog (yeast)                                1.38
  ILMN_1254295        Sox21                              SRY-box containing gene 21                             1.38
  ILMN_3091003        Ms4a7       membrane-spanning 4-domains, subfamily A, member 7, transcript variant 1      1.37
  ILMN_2667829        Prkcq                               protein kinase C, theta                               1.37
  ILMN_2776034         Gal                                        galanin                                       1.37
  ILMN_2651582    9630031F12Rik                          RIKEN cDNA 9630031F12 gene                             1.35
  ILMN_1229763        Dmkn                            dermokine, transcript variant 2                           1.34
  ILMN_1236758        Wfdc2                           WAP four-disulfide core domain 2                          1.33
  ILMN_2715840        C1qc                    complement component 1, q subcomponent, C chain                   1.32
  ILMN_2593774    1190002H23Rik                          RIKEN cDNA 1190002H23 gene                             1.31
  ILMN_1218223        Pvalb                                     parvalbumin                                     −1.62

Validation of the microarray by quantitative RT-PCR {#s3b}
---------------------------------------------------

Among the DEGs, 16 candidate genes were selected to validate by qRT-PCR; the DEGs were chosen for either their fold changes (\>1.5) and/or potential roles associated with inner ear development ([Table 2](#pone-0097544-t002){ref-type="table"}). These genes included *Tectb*, *Otoa*, and *Esrrb*, the mutations of which are associated with hearing loss [@pone.0097544-Richardson1]--[@pone.0097544-Ghaffari1]. In addition, peptide YY (*Pyy*) and integrin beta 6 (*Itgb6*) were identified; these have not been previously reported in the mammalian inner ear. For all analyzed upregulated genes in *Pten* cKO compared to wild-type mice, the average fold change from the qRT-PCR results showed a significant correlation of gene expression changes, as revealed by the microarray data (Pearson\'s correlation coefficient, *r* = 0.876). This result indicates that changes in the expression of selected DEGs were validated by qRT-PCR while confirming the gene expression results obtained by microarray analysis.

10.1371/journal.pone.0097544.t002

###### Genes selected for validation of microarray data by qRT-PCR.

![](pone.0097544.t002){#pone-0097544-t002-2}

                          Average fold change  
  -------- ------------- --------------------- -------
  Ttr       NM_013697.3          3.94           15.53
  Ltf       NM_008522.3          2.28           5.40
  S100a8    NM_013650.2          2.00           6.21
  Pyy       NM_145435.1          1.87           4.52
  S100a9    NM_009114.1          1.85           7.09
  Spp1      NM_009263.1          1.83           3.62
  Tectb     NM_009348.3          1.71           6.64
  Otoa      NM_139310.1          1.67           3.02
  Mt1       NM_013602.2          1.67           4.73
  Itgb6     NM_021359.2          1.64           6.42
  Dct       NM_010024.2          1.57           3.99
  Rgs4      NM_009062.3          1.56           3.24
  Esrrb     NM_011934.3          1.56           4.43
  Pik3r3    NM_181585.5          1.52           3.58
  Hap1      NM_010404.2          1.51           2.58
  Pvalb     NM_1218223           −1.62          0.40

*In situ* expression patterns for selected candidates {#s3c}
-----------------------------------------------------

To confirm the changes in expression of DEGs in the inner ear, we performed *in situ* hybridization for the selected DEGs, *i*.*e*., *Otoa*, *Tectb*, *Pvalb*, *Spp1*, and *Rgs4* ([Figs. S1](#pone.0097544.s001){ref-type="supplementary-material"} and 2). Higher expression of *Otoa* and *Tectb* was observed in the cochlea of *Pten* cKO mice than in the cochlea of wild-type mice ([Fig. S1A](#pone.0097544.s001){ref-type="supplementary-material"}--D). Many studies have reported that mutations in *Otoa* and *Tectb* cause hearing loss [@pone.0097544-Richardson1], [@pone.0097544-Lee1], [@pone.0097544-Zwaenepoel1]--[@pone.0097544-Ghaffari1]. Inner ear-specific *Otoa* is reportedly expressed on the surface of the spiral limbus and greater epithelial ridge in the cochlea. Mutant mice lacking *Otoa* showed that otoancorin is required for the attachment of the tectorial membrane (TM) to the surface of the spiral limbus [@pone.0097544-Zwaenepoel1], [@pone.0097544-Lukashkin1]. The TM is composed of collagen proteins, and other non-collagen proteins such as α-tectorin and β-tectorin, and all essential for auditory function. *Tectb*-null mutant mice develop deafness as well as mutation of *Tecta* [@pone.0097544-Ghaffari1], [@pone.0097544-Russell1]. Further functional characterization is needed to determine whether a *Pten* deficiency-induced upregulated pattern of *Otoa* and *Tectb* expression leads to abnormal function of the TM.

In particular, changed expression levels of several genes were detected in the *Pten*-deficient SGNs; i.e., *Pvalb*, *Spp1*, and *Rgs4*. We found that the levels of *Pvalb*, a neuronal marker [@pone.0097544-Huang1], were downregulated ([Fig. S1E](#pone.0097544.s001){ref-type="supplementary-material"}, F). Reduced levels of *Pvalb* expression may be explained by the loss of *Pvalb-*expressing neurons in *Pten*-deficient mice. We observed increased levels of *Spp1* (also known as osteopontin, *Opn*) and *Rgs4* expression in *Pten*-deficient SGNs compared to the wild-type ([Fig. 2](#pone-0097544-g002){ref-type="fig"}). In the cochlea and vestibular dark cells, *Spp1* may be responsible for regulation of ions in the inner ear fluid. The role of Spp1 in SGNs may be associated with regulation of nitric oxide production, which is considered to be associated with auditory neurotransmission in adenosine triphosphate (ATP)-induced Ca^2+^ signaling [@pone.0097544-Sakagami1], [@pone.0097544-Davis1]. Functionally, several lines of evidence have shown that *Spp1* may play a role in neurodegeneration [@pone.0097544-Comi1], [@pone.0097544-Iczkiewicz1]. Upregulation of SPP1 was detected in lesions or within the cerebral or spinal fluid in patients with neurodegenerative conditions such as Alzheimer\'s and Parkinson\'s diseases. *Spp1*-knockout mice showed reduced neurodegeneration induced by MPTP [@pone.0097544-Maetzler1]. Following crush injury to the optic nerve, strongly expressed Spp1 by macrophages may have inhibitory effects on axon growth [@pone.0097544-Kury1]. Therefore, inhibition of axon outgrowth described in *Pten* cKO mice (i.e., shortened length of spiral ganglion toward the modiolus) may be at least partly explained by the dysregulation of *Spp1* expression in SGNs.

![Expression patterns of *Spp1* and *Rgs4* during inner ear development.\
Expression levels of *Spp1* (A, B) and *Rgs4* (C, D) were examined by *in situ* hybridization at E14.5. Both *Spp1* and *Rgs4* expression were observed in SGNs. Consistent with the microarray results, expression levels of *Spp1* and *Rgs4* were increased in the *Pten* cKO compared to wild-type mice. Scale bars: 100 µm.](pone.0097544.g002){#pone-0097544-g002}

Inhibitory regulators of G protein signaling 4 (*RGS4*), a schizophrenia susceptibility gene, is one of the RGS that includes the Gαi/o and Gαq families and is required for modulation of neurotransmission in the nervous system [@pone.0097544-Hains1], [@pone.0097544-Ding1]. In mice, the expression of *Rgs4* is observed in peripheral and central neuronal precursors [@pone.0097544-Grillet1], [@pone.0097544-Grillet2]. In the chicken spinal cord, *Rgs4* has been suggested to play a role in neuronal differentiation in cooperation with paired-like homeodomain protein PHOX2b and the basic helix-loop-helix protein MASH1 [@pone.0097544-Grillet1]. Thus, our data suggest that the increased expression of *Rgs4* in the *Pten*-deficient SGNs compared to wild-type mice may play a role in neurogenesis.

Network analysis {#s3d}
----------------

To examine signaling networks during neuronal maintenance in the *Pten*-deficient inner ear, networks were subjected to IPA analysis with 82 DEGs (FDR\<0.05) ([Fig. 3](#pone-0097544-g003){ref-type="fig"}). IPA analysis identified significant biological functions, including auditory disease, cell death and survival, and cellular movement (data not shown). Auditory diseases included *Otoa*, *Tectb*, estrogen-related receptor beta (*Esrrb*), and solute carrier family 26 member 4 (*Slc26A4*), which may explain the functional defects of the developing inner ear. Cell death and survival-related genes were enriched, including phosphatase 2A regulatory subunit B beta2 (*Ppp2r2b*), S100 calcium-binding protein A8 (*S100A8*), *S100A9*, insulin-like growth factor-binding protein 7 (*Igfbp7*), and cathelicidin antimicrobial peptide (*Camp*).

![Functional network analysis associated with *Pten*-deficient inner ear.\
Network analysis using the Ingenuity Pathway Analysis (IPA) software was conducted using selected genes that were differentially expressed and their close relationships. IPA results show two core networks consisted of *Spp1*-(red line) and *Rgs4*-associated interactions (blue line). Genes that were differentially expressed are indicated in pink, and predicted interacting genes (not contained in the microarray data) are indicated in white. Axon guidance signaling pathway-related genes are outlined in magenta. Molecular interactions between connected genes represent direct (solid line) or indirect (dotted line) functional relationships based on the IPA database. Green indicates negative fold changes, while red denotes positive fold changes, according to color intensity.](pone.0097544.g003){#pone-0097544-g003}

In particular, cellular movement included *Spp1*-mediated cell adhesion or migration, which was connected to *S100a8*, *S100a9*, *Integrin*, focal adhesion kinase (*Fak*), lipocalin2 (*Lcn2*), *Camp*, and FMS-related tyrosine kinase 1 (*Flt1*). The chemoattractant activity of SPP1 has been reported in various cell types, some of which interact with integrins such as α~ν~β~3~ [@pone.0097544-Mi1]--[@pone.0097544-Wai1]. Dysregulated levels of SPP1 have been implicated in cellular migration; i.e., SPP1 produced by macrophages and microglia induces lateral migration of neuroblasts after focal cerebral ischemia [@pone.0097544-Yan1]. Furthermore, SPP1 directly induces migration of human lung cancer cells (A549cells) through activation of α~ν~β~3~ integrins, focal adhesion kinase (FAK), p85 subunit of PI3K, serin 473 of AKT and ERK, and the NF-κB-dependent signaling pathway [@pone.0097544-Fong1]. In our recent study, we detected abnormal neuronal migration with increases in Akt phosphorylation at the Ser473 residue in SGNs of *Pten* cKO mice. Taken together, our results suggest that elevation of *Spp1* produced by SGNs may affect neuronal cell movement in *Pten*-deficient mice compared with wild-type mice. Further experiments are required to elucidate the mechanism by which altered *Spp1* expression induces disturbance of neuronal migration through Akt activation in SGNs.

Regarding the significance of the canonical pathway (data not shown), IPA identified that the Gαq signaling pathway (*p*\<0.05) is associated with *Rgs4* ([Fig. 3](#pone-0097544-g003){ref-type="fig"}). Gαq signaling is related to axon outgrowth, which is supported by the results from *RGS4* mutant models [@pone.0097544-Katoh1], [@pone.0097544-Cheng1]. Although *Rgs4*-deficient mice exhibit a normal neuronal phenotype, their behavioral abnormality suggests defects in axonogenesis [@pone.0097544-Grillet2]. In zebrafish, an rgs4^−/−^ mutant showed defects in motility and axonogenesis and attenuation of the phosphorylated Akt1 level in the spinal cord [@pone.0097544-Cheng1]. This evidence indicates a novel role for rgs4 in regulating Akt1-mediated axonogenesis. We suggest that increased expression of *Rgs4* in the *Pten*-deficient SGNs, compared with the wild-type, may affect axon outgrowth regulation functionally mediated by the PI3K/Akt signaling pathway due to the increased levels of phosphorylated Akt in SGNs of *Pten* cKO mice. While the biological function of the Rgs4-Akt signaling pathway in the developing SGNs is not fully understood, we suggest that Rgs4-Akt-mediated signaling networks may be associated with neuronal defects in the *Pten*-deficient SGNs (e.g., abnormal path-finding of neurites and irregularly gathered radial bundles).

Finally, IPA analysis revealed two core gene (*Spp1*; red line and *Rgs4*; blue line)-mediated networks in SGNs of the *Pten*-deficient inner ear ([Fig. 3](#pone-0097544-g003){ref-type="fig"}). These networks were also associated with the axonal guidance signaling pathway, which includes several mediators, such as G protein, frizzled homolog 6 (*Drosophila*) (*Fzd6*), protein kinase C (*Pkc*), *Akt*, *PI3K*, *Erk1/2*, *Fak*, and *Pkc* theta (*Prkcq*). Therefore, we suggest that partially modulated functions of the axonal guidance signaling pathway are involved in axonal development in *Pten* cKO mice [@pone.0097544-Ratnaparkhi1]--[@pone.0097544-Stuebner1].

Conclusions {#s4}
===========

In this study, we investigated profiles of significantly differentially expressed transcripts and their respective networks associated with *Pten* deficiency in the developing inner ear at E14.5. We suggest the presence of core signaling networks mediated by upregulated expression of *Spp1* and *Rgs4*, which also include several key factors associated with apoptosis, cellular movement, and axon guidance. This may be explained in terms of phenotypic defects implicated in neuronal differentiation of *Pten*-deficient SGNs during inner ear development (e.g., neuronal apoptosis, shortened axon length, abnormal cell movement, and irregular neurite path-finding of SGNs). Our gene expression profiles will facilitate understanding of the neuronal maintenance in developing spiral ganglion. However, the functional roles of these candidates should be examined in future studies.
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Expression patterns of *Otoa*, *Tectb*, and *Pvalb* during inner ear development at E14.5. Expression levels of *Otoa* (A, B), *Tectb* (C, D), and *Pvalb* (E, F) were determined by *in situ* hybridization at E14.5. *Otoa* transcripts were identified on the surface of the spiral limbus and greater epithelial ridge in the cochlea (A, B). Expression domains of *Tectb* were observed in the sensory epithelium of the cochlea (C, D). The neuronal marker *Pvalb* was expressed in SGNs (E, F). Consistent with the microarray data, the expression levels of *Otoa* (B) and *Tectb* (D) were higher, and that of *Pvalb* (F) was lower, in *Pten* cKO mice than in wild-type mice. Scale bars: 100 µm.
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